Skip to content
World Today News
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Technology
  • World
World Today News
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Technology
  • World
Saturday, December 6, 2025
World Today News
World Today News
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Technology
  • World
Copyright 2021 - All Right Reserved
Home » infectious disease » Page 5
Tag:

infectious disease

Health

GSK’s world-first gonorrhoea vaccine launched in England

by Dr. Michael Lee – Health Editor August 5, 2025
written by Dr. Michael Lee – Health Editor

England Rolls Out World-First Gonorrhoea Vaccine

Hoping to curb soaring infection rates and ease NHS burden.

England has pioneered a new public health initiative, launching the United Kingdom’s first gonorrhoea vaccination program. This pioneering effort aims to prevent a significant number of new infections and substantially reduce the strain on National Health Service resources.

Targeting High-Risk Groups

The program will offer GSK’s 4CMenB vaccine free of charge to individuals identified as being at the highest risk of contracting this sexually transmitted infection. This includes gay and bisexual men who have had multiple sexual partners or have been diagnosed with a bacterial STI within the last twelve months.

The Department of Health and Social Care anticipates that vaccinating those most vulnerable will help curb the alarming rise in gonorrhoea cases. Projections suggest the program could avert as many as 100,000 infections over time, potentially saving the NHS more than £7.9 million in funding over the next decade.

Rising Infections Prompt Action

This preventative measure comes as gonorrhoea diagnoses in England have reached unprecedented levels. In 2023, a record 85,000 cases were reported, a threefold increase compared to 2012. A key driver of this surge is the growing prevalence of antibiotic-resistant strains, a challenge the new vaccine is designed to confront.

In 2023, England recorded a record 85,000 cases of gonorrhoea, a significant increase from previous years. Credit: KomootP via Shutterstock.com.

Repurposed Vaccine Faces New Challenge

The 4CMenB vaccine, originally developed by GSK to protect against meningococcal B disease, received European approval in 2013 and was introduced into the UK’s routine childhood immunisation schedule in 2015. Its use for gonorrhoea prevention, however, is currently considered off-label.

Following encouraging evidence suggesting its potential efficacy against gonorrhoea, the UK’s Joint Committee on Vaccination and Immunisation reviewed the vaccine’s suitability in late 2023. After evaluating immunogenicity data and cost-effectiveness analyses, the committee recommended the targeted vaccination strategy for high-risk populations.

Expert Endorsement and Future Treatments

Dr. **Sema Mandal**, a consultant epidemiologist at the UK Health Security Agency, welcomed the rollout. “This rollout is hugely welcome as we’re currently seeing very concerning numbers of gonorrhoea, including even more worryingly antibiotic-resistant gonorrhoea,” she stated. “The vaccine will give much-needed protection to those that need it most – making the UK a world leader in the fight against gonorrhoea.”

GSK is also advancing a new oral antibiotic, gepotidacin, for treating gonorrhoea in adolescents and adults. Recent Phase III trial results for this candidate, marketed as Blujepa, have shown strong efficacy against antibiotic-resistant strains. The US Food and Drug Administration approved Blujepa in March 2025 for treating urinary tract infections.

August 5, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

Rising anti-vaccine sentiment in U.S. will exact heavy toll overseas

by Dr. Michael Lee – Health Editor August 5, 2025
written by Dr. Michael Lee – Health Editor

Gates Foundation Doubles Down on Global Health, Announces $2.5 Billion Women’s Health Investment Amidst Eradication efforts

geneva, Switzerland – August 7, 2025 – Bill Gates today reaffirmed the Gates Foundation’s commitment to global health initiatives, announcing a new $2.5 billion pledge focused on women’s health. The announcement comes as the foundation continues to heavily invest in the eradication of polio and explores the ambitious goal of eradicating measles,despite growing challenges and skepticism in wealthier nations.

The foundation’s continued focus on these diseases stems from a stark reality: preventable infectious diseases contribute to a significantly higher death rate in lower-income countries compared to richer nations.This disparity underscores the critical need for sustained investment in global health infrastructure and vaccine development.

Long-Term Context: The Fight Against Infectious Disease

For decades, the Gates Foundation has been a leading force in the fight against infectious diseases. Their current portfolio includes ambitious projects aimed at eliminating some of the world’s most devastating illnesses.

Currently, the foundation is funding research into a novel combination vaccine targeting polio, malaria, and measles. This vaccine, designed for delivery via a patch instead of a customary injection, represents a potential breakthrough in accessibility and ease of governance, notably in resource-constrained settings. the development is fueled by the possibility of eradicating measles – a feat only achieved once in human history with smallpox.

The eradication of a disease requires interrupting its transmission. Measles is a particularly promising target because the virus exclusively infects humans, meaning eliminating human-to-human transmission would effectively eliminate the virus globally. However, this ambition is threatened by increasing vaccine hesitancy, particularly in developed countries, where unfounded claims linking measles vaccines to autism have gained traction.

“Now we’re going to have to say, does rich country skepticism alone mean that we will not take on measles eradication?” Gates questioned, highlighting the potential for localized resistance to derail a global effort.

Polio Eradication: A Near Miss?

The foundation remains steadfast in its commitment to polio eradication, a campaign it has spearheaded for nearly four decades. Despite meaningful progress, the virus persists in only two countries: Pakistan and Afghanistan. As of this year, these two nations have reported a combined total of 19 cases of paralytic polio, according to data from the polioeradication.org.gates emphasized the devastating consequences of abandoning the polio eradication effort. He warned that halting funding would likely lead to a resurgence of the disease, potentially paralyzing up to 100,000 children annually, primarily in Africa and Asia. While improved sanitation and economic development in some regions might limit the spread in wealthier countries, the impact on vulnerable populations would be catastrophic.

Acknowledging the ample financial investment already made,Gates admitted a potential bias towards continuing the program. “Once you spend billions of dollars on something, maybe you’re biased towards hoping that it effectively works,” he said, but ultimately concluded, “I think I’m being objective to say, no, this is money that we’re going to continue to spend.”

Looking Ahead: Funding and Future Challenges

Gates also expressed optimism about the potential for restoring funding to global health initiatives, specifically referencing cuts made by the U.S. government with the closure of parts of the U.S. Agency for International Development. He stated the foundation would actively advocate for the reinstatement of these funds.

Key Details Not Explicitly Mentioned in the Original Article:

The specific focus areas within the $2.5 billion women’s health pledge were not detailed. (The linked article provides more specifics on this.)
The type of patch technology being developed for the combination vaccine was not specified. (Further research would be needed to understand the delivery mechanism.)
* The historical peak of polio cases prior to the eradication efforts was not quantified. (While the article mentions a peak, the specific number of annual cases was not provided.)

August 5, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

Hand, foot and mouth disease cases rising across multiple parts of US

by Dr. Michael Lee – Health Editor August 4, 2025
written by Dr. Michael Lee – Health Editor

“`html

Hand, foot and mouth disease cases rising across multiple parts of US

An increase in Hand, Foot, and Mouth Disease (HFMD) cases is being reported across the United States, prompting health officials to issue preventative guidance. (iStock)

WASHINGTON D.C. – Health officials are observing a rise in cases of Hand, Foot, and Mouth Disease (HFMD) across the united States, particularly impacting children in daycare and school settings, according to reports surfacing this week. While typically mild, the highly contagious viral illness can, in rare instances, lead to serious neurological complications.

HFMD is most commonly caused by the Coxsackievirus A16 and Enterovirus 71 viruses. Symptoms typically include

August 4, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

Justin Timberlake Suffers from Lyme Borreliosis: Symptoms and What You Need to Know

by Dr. Michael Lee – Health Editor August 1, 2025
written by Dr. Michael Lee – Health Editor

Justin Timberlake recently revealed he is battling Lyme disease, a condition that can manifest with flu-like symptoms such as fever, headache, fatigue, and muscle or joint pain. These were reportedly the symptoms that increasingly affected the singer while performing on stage.

Lyme disease, if caught early, is highly treatable with antibiotics. Though, if left untreated, the bacteria responsible can spread through the bloodstream to various parts of the body, potentially causing severe symptoms. Key areas affected can include the nervous system (leading to neuroborreliosis), joints (lyme arthritis), and skin. In rare instances, other organs can also be impacted.

Neuroborreliosis, a form of Lyme disease affecting the nervous system, can be particularly debilitating. Individuals may experience numbness, paralysis, or burning nerve pain. Psychological effects such as difficulty concentrating and exhaustion are also reported.Timberlake himself described the illness as “grueling” both physically and mentally.

The prognosis for Lyme disease is generally positive, with over 95 percent of cases fully recovering with prompt diagnosis and treatment. A typical course of treatment involves two to three weeks of antibiotics, commonly including doxycycline or amoxicillin. Early medical consultation is crucial, especially if characteristic symptoms arise after a tick bite or if a rash is observed.

August 1, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

ViiV HIV Drug Access Expanded: Licensing Deal for Long-Acting Treatment

by Dr. Michael Lee – Health Editor July 15, 2025
written by Dr. Michael Lee – Health Editor

GSK Expands HIV Drug Licensing to Include Treatment Regimens

GSK has broadened a three-year-old licensing agreement with the Medicines Patent Pool, a United Nations-backed organization, to allow generic manufacturers to produce its long-acting HIV medication, cabotegravir, for treatment purposes.Previously, the agreement focused solely on HIV prevention.

This expansion enables existing generic licensees to develop, manufacture, and distribute versions of cabotegravir for use in combination with Johnson & Johnson’s long-acting rilpivirine. This development follows updated guidance from the World health Organization,which now recommends this combination as a treatment option for HIV.

July 15, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

Danish study debunks danger of aluminum in vaccines

by Dr. Michael Lee – Health Editor July 15, 2025
written by Dr. Michael Lee – Health Editor

“`html

Danish Study Finds No Link Between Aluminum in Vaccines and Neurological Disorders

Table of Contents

  • Danish Study Finds No Link Between Aluminum in Vaccines and Neurological Disorders
    • Breaking News:
    • Evergreen Context:
      • Related Article:

A large-scale study from Denmark has provided further evidence that aluminum-adjuvanted vaccines, widely used in childhood immunization programs, do not increase the risk of neurological disorders.

Breaking News:

A comprehensive study conducted in Denmark has found no association between the aluminum content in routine childhood vaccines and the development of neurological disorders. The research, which analyzed a significant population cohort, reinforces the established safety profile of these essential vaccines.

Evergreen Context:

Aluminum has been used as an adjuvant in vaccines for decades. Adjuvants are substances added to vaccines to help create a stronger immune response, making the vaccine more effective. While concerns about aluminum in vaccines have been raised, numerous studies, including this recent Danish research, have consistently found no evidence of harm.

The Danish study, led by Anders Hviid of the Statens Serum Institut, examined a large group of children and found no increased risk of conditions such as autism, ADHD, or Tourette syndrome in those who received aluminum-containing vaccines compared to those who did not. researchers specifically looked for a dose-response relationship, meaning thay investigated whether higher doses of aluminum where linked to a greater risk, and found no such correlation.

Dr. Michael Daley, a pediatrician and vaccine researcher, commented on the findings, stating that the study’s design was intended to detect a dose-response relationship if one existed, and its absence is significant. He acknowledged minor differences in vaccine schedules between Denmark and the United States, noting that Denmark typically immunizes at 3, 5, and 12 months, while the U.S. schedule includes immunizations at 2, 4, 6, and 12 months. Though, Daley expressed that he would be surprised if this slight difference significantly impacted the study’s conclusions.

Notably this study, like many others in vaccine safety research, is observational and not a randomized controlled trial. Conducting a trial where some children are intentionally denied vaccines containing aluminum would be unethical, as it would put them at risk of preventable diseases. However, the scale and clarity of the Danish study’s results underscore the safety of these vaccines.

Hviid emphasized the critical role of aluminum-adjuvanted vaccines in global immunization efforts. He stated, “These aluminum-adjuvanted vaccines are really important for our immunization programs. Not just in Denmark, not just in the U.S., but globally. We don’t have any replacements for these vaccines with other adjuvants. So if you take them away, children are going to die.” The continued reliance on these vaccines highlights their proven efficacy and safety in preventing serious infectious diseases.

Related Article:

July 15, 2025 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Search:

Recent Posts

  • Müller vs. Messi: A History of Dominance Ahead of MLS Final

    December 6, 2025
  • Name change for CineMec Cinema in Ede – Pathé Takes Over

    December 6, 2025
  • Title: 2026 World Cup: Trump’s Bandage Sparks Health Concerns

    December 6, 2025
  • Instagram and the silent effect of materialism

    December 6, 2025
  • Bismarck Restaurant Eviction: Court Delays Dispute Over Back Rent

    December 6, 2025

Follow Me

Follow Me
  • Live News Feeds
  • Short Important News
  • Most Important News
  • Headlinez
  • Most Recommended Web Hosting
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Copyright Notice
  • Disclaimer
  • DMCA Policy
  • EDITORIAL TEAM
  • Links
  • Privacy Policy
  • Terms & Conditions

@2025 - All Right Reserved.

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: contact@world-today-news.com


Back To Top
World Today News
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Technology
  • World
World Today News
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Technology
  • World
@2025 - All Right Reserved.

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: contact@world-today-news.com